{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:01:49Z","timestamp":1790204509838,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antimicrobial agents are administered via intramedullary antibiotic perfusion (iMAP)\/intrasoft tissue antibiotic perfusion (iSAP) to infected lesions to control osteoarticular and soft tissue infections. Continuous local antibiotic perfusion (CLAP) has been reported to be useful. This study aimed to investigate the outcomes of DAIR combined with CLAP for chronic PJI after total knee arthroplasty performed at our hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and methods<\/jats:title>\n                    <jats:p>Six patients (male; one case, female; five cases, mean age 79.5 years (70\u201394)) underwent CLAP for chronic PJI after TKA at our hospital between July 2020 and June 2022. They were followable for at least one year after surgery. Seven months (17\u2013219), with a mean follow-up of 24.3 months (12\u201336). In addition to direct debridement and insert exchange, systemic antimicrobial treatment, and CLAP with gentamicin were performed using NPWT. We investigated the organisms causing the inflammation, the duration of iMAP\/iSAP implantation, the maximum daily dose of GM, the maximum GM blood concentration, and the presence or absence of GM-induced adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Two of six patients had a recurrence of infection at five weeks and five months after initial CLAP and required\n                      <jats:underline>repeat CLAP treatment<\/jats:underline>\n                      , but all patients could preserve their components. The organisms responsible for the flare-ups were MSSA in three cases: ESBL-producing\n                      <jats:italic>E. coli<\/jats:italic>\n                      , mixed MSSA and streptococcal infection,\n                      <jats:italic>Klebsiella<\/jats:italic>\n                      pneumonia in one case each, and unknown pathogens in one case. CLAP therapy for all patients was administered eight times in 6 cases: iMAP, mean: 10.0 days (5\u201316); iSAP, mean: 19.3 days (15\u201328); GM dose, mean: 162.5\u00a0mg\/day (80\u2013240); and GM blood concentration, mean: 1.4\u00a0\u00b5g\/mL (0.2-5.0). Adverse events included one case of reversible acute kidney injury during CLAP in a patient with recurrent infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>DAIR with CLAP for chronic post-TKA infection can be a useful treatment option to preserve components and allow the infection to subside, provided the implant is not markedly loosened.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-024-07165-y","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:02:55Z","timestamp":1704412975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["DAIR in treating chronic PJI after total knee arthroplasty using continuous local antibiotic perfusion therapy: a case series study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yukichi","family":"Zenke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Motojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"7165_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1302\/2046-3758.119.BJR-2022-0078.R1","volume":"11","author":"IK Sigmund","year":"2022","unstructured":"Sigmund IK, Luger M, Windhager R, McNally MA. Diagnosing periprosthetic joint Infections: a comparison of Infection definitions: EBJIS 2021, ICM 2018, and IDSA 2013. Bone Joint Res. 2022;11:608\u201318.","journal-title":"Bone Joint Res"},{"key":"7165_CR2","doi-asserted-by":"publisher","first-page":"e1900224","DOI":"10.2106\/JBJS.RVW.19.00224","volume":"8","author":"R Miller","year":"2020","unstructured":"Miller R, Higuera CA, Wu J, Klika A, Babic M, Piuzzi NS. Periprosthetic joint Infection: a review of antibiotic treatment. JBJS Rev. 2020;8:e1900224.","journal-title":"JBJS Rev"},{"key":"7165_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5194\/jbji-6-329-2021","volume":"6","author":"B Van der Ende","year":"2021","unstructured":"Van der Ende B, Van Oldenrijk J, Reijman M, Croughs PD, Van Steenbergen LN, Verhaar JAN, et al. Timing of debridement, antibiotics, and implant retention (DAIR) for early post-surgical hip and knee prosthetic joint Infection (PJI) does not affect 1-year re-revision rates: data from the Dutch Arthroplasty Register. J Bone Jt Infect. 2021;6:329\u201336.","journal-title":"J Bone Jt Infect"},{"key":"7165_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0968-0160(02)00046-7","volume":"9","author":"EC Papadopoulos","year":"2002","unstructured":"Papadopoulos EC, Parvizi J, Lai CH, Lewallen DG. Total knee arthroplasty following prior distal femoral fracture. Knee. 2002;9:267\u201374.","journal-title":"Knee"},{"key":"7165_CR5","doi-asserted-by":"publisher","first-page":"230949902110514","DOI":"10.1177\/23094990211051492","volume":"29","author":"A Maruo","year":"2021","unstructured":"Maruo A, Oda T, Miya H, Muratsu H, Fukui T, Oe K, et al. Intra-medullary antibiotics perfusion (iMAP) for the control of fracture-related Infection early after osteosynthesis. J Orthop Surg (Hong Kong). 2021;29:23094990211051492.","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"7165_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jos.2020.11.010","volume":"27","author":"D Himeno","year":"2022","unstructured":"Himeno D, Matsuura Y, Maruo A, Ohtori S. A novel treatment strategy using continuous local antibiotic perfusion: a case series study of a refractory Infection caused by hypervirulent Klebsiella pneumoniae. J Orthop Sci. 2022;27:272\u201380.","journal-title":"J Orthop Sci"},{"key":"7165_CR7","first-page":"1741","volume":"11","author":"K Kosugi","year":"2022","unstructured":"Kosugi K, Zenke Y, Sato N, Hamada D, Ando K, Okada Y, et al. Potential of continuous local antibiotic perfusion therapy for fracture-related Infections. Infect Dis Ther. 2022;11:1741\u201355.","journal-title":"Infect Dis Ther"},{"key":"7165_CR8","first-page":"2563939","volume":"2022","author":"S Takahara","year":"2022","unstructured":"Takahara S, Maruo A, Takayama H, Harada T. Continuous local antibiotics perfusion therapy for acute deep Infections after open fractures. Case Rep Orthop. 2022;2022:2563939.","journal-title":"Case Rep Orthop"},{"key":"7165_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/jor.24229","volume":"37","author":"K Saeed","year":"2019","unstructured":"Saeed K, McLaren AC, Schwarz EM, Antoci V, Arnold WV, Chen AF, et al. 2018 international consensus meeting on musculoskeletal Infection: summary from the biofilm workgroup and consensus on biofilm related musculoskeletal Infections. J Orthop Res. 2019;37:1007\u201317.","journal-title":"J Orthop Res"},{"key":"7165_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint Infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1\u201325.","journal-title":"Clin Infect Dis"},{"key":"7165_CR11","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s11999-016-4700-z","volume":"474","author":"P Castaneda","year":"2016","unstructured":"Castaneda P, McLaren A, Tavaziva G, Overstreet D. Biofilm antimicrobial susceptibility increases with antimicrobial exposure time. Clin Orthop Relat Res. 2016;474:1659\u201364.","journal-title":"Clin Orthop Relat Res"},{"key":"7165_CR12","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","volume":"37","author":"H Ceri","year":"1999","unstructured":"Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37:1771\u20136.","journal-title":"J Clin Microbiol"},{"key":"7165_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/AAC.03676-14","volume":"59","author":"RP Howlin","year":"2015","unstructured":"Howlin RP, Brayford MJ, Webb JS, Cooper JJ, Aiken SS, Stoodley P. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic Infections. Antimicrob Agents Chemother. 2015;59:111\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"7165_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/jbji.29711","volume":"4","author":"V Badha","year":"2019","unstructured":"Badha V, Moore R, Heffernan J, Castaneda P, McLaren A, Overstreet D. Determination of tobramycin and Vancomycin exposure required to eradicate biofilms on muscle and bone tissue in vitro. J Bone Jt Infect. 2019;4:1\u20139.","journal-title":"J Bone Jt Infect"},{"key":"7165_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jor.24616","volume":"39","author":"EM Schwarz","year":"2021","unstructured":"Schwarz EM, McLaren AC, Sculco TP, Brause B, Bostrom M, Kates SL, et al. Adjuvant antibiotic-loaded bone cement: concerns with current use and research to make it work. J Orthop Res. 2021;39:227\u201339.","journal-title":"J Orthop Res"},{"key":"7165_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3109\/14397595.2015.1031360","volume":"25","author":"H Choe","year":"2015","unstructured":"Choe H, Inaba Y, Kobayashi N, Miyamae Y, Ike H, Saito T. Clinical utility of antibiotic-loaded hydroxyapatite block for treatment of intractable periprosthetic joint Infection and septic arthritis of the hip. Mod Rheumatol. 2015;25:937\u201342.","journal-title":"Mod Rheumatol"},{"key":"7165_CR17","first-page":"1","volume":"42","author":"A Maruo","year":"2020","unstructured":"Maruo A, Fukui T, Oe K, Niikura T, Zenke Y. Pharmacokinetics of antimicrobials administered into cadaveric tibial bone marrow from intra-medullary antibiotics perfusion (iMAP). Kossetsu. 2020;42:1\u20135. (in Japanese).","journal-title":"Kossetsu"},{"key":"7165_CR18","first-page":"23","volume":"35","author":"Y Zenke","year":"2022","unstructured":"Zenke Y, Ando K, Hamada D, Sato N, Himeno D, Takahara S, et al. [Practical application of CLAP to suppress bone and soft tissue Infection] how to construct CLAP how it behaves in the body how to make it from experiments using cadavers? Orthopaedics. 2022;35:23\u201332. (in Japanese).","journal-title":"Orthopaedics"},{"key":"7165_CR19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11999-010-1425-2","volume":"469","author":"YH Kim","year":"2011","unstructured":"Kim YH, Choi Y, Kim JS. Treatment based on the type of infected TKA improves Infection control. Clin Orthop Relat Res. 2011;469:977\u201384.","journal-title":"Clin Orthop Relat Res"},{"key":"7165_CR20","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1007\/s00402-023-04891-1","volume":"143","author":"CE Okafor","year":"2023","unstructured":"Okafor CE, Nghiem S, Byrnes J. One-stage revision versus debridement, antibiotics, and implant retention (DAIR) for acute prosthetic knee Infection: an exploratory cohort study. Arch Orthop Trauma Surg. 2023;143:5787\u201392.","journal-title":"Arch Orthop Trauma Surg"},{"key":"7165_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1302\/0301-620X.104B4.BJJ-2021-1264.R1","volume":"104\u2013b","author":"K Veerman","year":"2022","unstructured":"Veerman K, Raessens J, Telgt D, Smulders K, Goosen JHM. Debridement, antibiotics, and implant retention after revision arthroplasty: antibiotic mismatch, timing, and repeated DAIR associated with poor outcome. Bone Joint J. 2022;104\u2013b:464\u201371.","journal-title":"Bone Joint J"},{"key":"7165_CR22","first-page":"249","volume":"9","author":"EC Rodriguez-Merchan","year":"2021","unstructured":"Rodriguez-Merchan EC. Late acute hematogenous Infections after total knee arthroplasty: results of debridement, antibiotics, and implant retention. Arch Bone Jt Surg. 2021;9:249\u201354.","journal-title":"Arch Bone Jt Surg"},{"key":"7165_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1051\/sicotj\/2016038","volume":"3","author":"SN Qasim","year":"2017","unstructured":"Qasim SN, Swann A, Ashford R. The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement - a literature review. SICOT J. 2017;3:2.","journal-title":"SICOT J"},{"key":"7165_CR24","first-page":"811","volume":"56","author":"K Gono","year":"2021","unstructured":"Gono K, Zenke Y, Tajima T, Suzuki H, Sato N, Sakai A. Therapeutic experience with continuous local antimicrobial perfusion therapy for pyogenic arthritis. Rinsyo Seikeigeka. 2021;56:811\u20137. (in Japanese).","journal-title":"Rinsyo Seikeigeka"},{"key":"7165_CR25","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic Kidney Disease: a position statement from Kidney Disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089\u2013100.","journal-title":"Kidney Int"},{"key":"7165_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1681\/ASN.2009060636","volume":"21","author":"JP Lafrance","year":"2010","unstructured":"Lafrance JP, Miller DR. Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 2010;21:345\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"7165_CR27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/jama.2009.1322","volume":"302","author":"R Wald","year":"2009","unstructured":"Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009;302:1179\u201385.","journal-title":"JAMA"},{"key":"7165_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/00016470510030355","volume":"76","author":"AJ Swieringa","year":"2005","unstructured":"Swieringa AJ, Tulp NJ. Toxic serum gentamicin levels after the use of gentamicin-loaded sponges in infected total hip arthroplasty. Acta Orthop. 2005;76:75\u20137.","journal-title":"Acta Orthop"},{"key":"7165_CR29","unstructured":"Hamada D, Zenke Y, Sato N, Ando K, Kosugi K, Sakai A. A study of drug-induced renal dysfunction cases during continuous local antibiotics perfusion therapy. Kossetsu. 2022;44:929\u2009\u2013\u200935.(in Japanese)."},{"key":"7165_CR30","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.arth.2018.02.087","volume":"33","author":"A Rajgopal","year":"2018","unstructured":"Rajgopal A, Panda I, Rao A, Dahiya V, Gupta H. Does prior failed debridement compromise the outcome of subsequent two-stage revision done for periprosthetic joint Infection following total knee arthroplasty? J Arthroplasty. 2018;33:2588\u201394.","journal-title":"J Arthroplasty"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-07165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-024-07165-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-07165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T12:03:30Z","timestamp":1704456210000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-024-07165-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7165"],"URL":"https:\/\/doi.org\/10.1186\/s12891-024-07165-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3360553\/v1","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"16 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Board (IRB) (UOEHCRB21-028) of the University of Occupational and Environmental Health, Japan. Study participants provided written informed consent for participating and using their data in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study participants provided written informed consent for participating and using their clinical data. Written informed consent for publication of their clinical details (the text and any pictures or video) was obtained from the patients or their relatives; such information will be treated confidentially.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest or competing interests concerning the work\u2019s research, authorship, and publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors and Maruo et al. run an organization called the CLAP Study Group (\n                      \n                      ), which promotes and raises awareness of CLAP therapy in Japan.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}}],"article-number":"36"}}